Fundraising Fox
Axil Capital
Venture capitalTokyo · Seed–Late Stage · 7 people tracked
Find your way into Axil Capital
Sign up to see every warm intro you have to Axil Capital
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Axil Capital team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Investment thesis
Axil Capital pursues a strategy of creating value in the life sciences venture ecosystem by identifying and nurturing transformational biotech and healthcare technologies across the full investment spectrum. The firm diversifies its portfolio across biopharmaceuticals, platform technologies, medical devices, digital health, and healthcare services. The investment thesis emphasizes establishing synergies between Japan's biotech ecosystem and global markets to build commercially viable enterprises with sustainable returns while addressing transformational needs in healthcare and medical innovation.
Source: firm website, verified Aug 5, 2026.
Team · 7 people
from the firm's website & public directories
What they invest in
from 5 of 5 portfolio companiesBiotech ×4Deep Tech ×2Healthtech ×2AI & Machine Learning ×1Digital Health ×1Longevity ×1Medical Devices ×1
HQs:Japan×2United States×2
Investments · 5 tracked
founders shown can be your intro pathBy year:2021 · 22020 · 12019 · 14 dated
LUCA Science develops mitochondrial therapies that supply functional, storable mitochondria to damaged or dysfunctional cells and tissues to restore cellular energy production, targeting conditions such as ischemia-reperfusion injuries including cerebral and myocardial infarction.
BiotechDeep TechHealthtechLongevity
Co-investorsAsahi Kasei Corporate Venture CapitalFast Track InitiativeRemiges Ventures, Inc.4BIO CapitalAstellas Venture Management LLCDCI Partners Co. Ltd.
MabGenesis is a Japanese startup biopharmaceutical company that commercializes decades of academic antibody research to develop first-in-class and best-in-class therapeutic monoclonal antibody drugs for both human and animal use.
BiotechDeep TechHealthtech
Co-investorsBeyond Next VenturesLong Black Partners
BiotechMedford, US
Giovanni Traverso(Director)inRobert Langer(Director)Carl Schoellhammer(Executive Officer, Director)inAmy Schulman(Director)
Co-investorsTaiwania Capital
TechsoMed develops BioTrace, an FDA-cleared software platform for image-guided minimally invasive cancer therapy that uses AI to provide real-time 3D visualization, tumor margin control, needle path planning, and post-ablation tissue response prediction.
AI & Machine LearningDigital HealthMedical Devices
Co-investorsNextLeap VenturesHelios Climate Ventures
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Frequently asked questions
- How many investments has Axil Capital made?
- Axil Capital has 5 tracked investments.
- What stage does Axil Capital invest at?
- Axil Capital invests at the Seed, Series A, Series B, Series C, Growth, Late Stage stages.
- What sectors does Axil Capital focus on?
- Axil Capital focuses on Biotech, Digital Health, Medical Devices.
- Where is Axil Capital located?
- Axil Capital is headquartered in Tokyo, JP.
Images
Co-investors · 2
Astellas Venture Management (AVM) is the wholly-owned corporate venture arm of Astellas, providing equity investments to private, early-stage biotechnology companies developing therapeutic programs and platform technologies for drug discovery.
Remiges Ventures is a venture capital firm focused on life sciences and drug discovery, backing biotech and therapeutics companies. It launched the RDiscovery Fund to incubate early-stage drug discovery projects.
Firms observed investing alongside Axil Capital, from public investor directories. Shared companies are the overlap with Axil Capital's recorded portfolio.
Similar investors
.jpeg){kind=logo}
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
GV (Google Ventures) is a venture capital firm that has invested in AI and machine learning since its early days, backing more than 100 AI companies across infrastructure, life sciences, and applications.
Menlo Ventures is an early-stage venture capital firm backing transformative technology companies, with a strong current emphasis on artificial intelligence across enterprise, healthcare, and consumer markets.
Norwest is a venture capital and growth equity investment firm that has backed over 700 companies across technology, consumer, and healthcare over its 65-year history.
Sofinnova is an investment firm focused on the life sciences and biotechnology sector, partnering with companies from inception through drug development, regulatory approval, company building, and IPO.